The multivariate analysis has shown NT-proBNP to be an effective short-term prognostic biomarker in discharged patients, especially when corrected with significant confounders, including renal function (eGFR), BMI, atrial fibrillation, serum sodium, and congestion markers. The gene discussed is NPPB; the disease is atrial fibrillation.